Clinical Trials Browser

Solid Tumors × TB-403 × Clear all

NCT00702494 2022-03-16

Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumors